Usually instos are restricted from investing in OTC markets so delisting normally drives further sell-off, significantly more dilution will occur if they can actually find funding in that market
That said, investors in the OTC usually have shallow pockets, I don't see how that could be beneficial
You actually think your post will have any weight on management decisions? That's a little bit delusional
Usually instos are restricted from investing in OTC markets so...
-
- There are more pages in this discussion • 22 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)